ANV 700
Alternative Names: ANV-700Latest Information Update: 08 Jan 2025
Price :
$50 *
At a glance
- Originator Anaveon
- Class Antibodies; Antineoplastics; Drug conjugates; Immunoconjugates; Immunotherapies; Interleukins; Recombinant fusion proteins
- Mechanism of Action Immunostimulants; Interleukin-21 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Preclinical Solid tumours